Image For Activity Cover
The Lead Episode 107: A Discussion of Catheter Ablation of AFib Patients with Cardiac Amyloidosis and Sarcoidosis: Procedural Outcomes and Findings LIVE from Heart Rhythm 2025
Description
Join HRS Board Member Prashanthan Sanders, MBBS, PhD, FHRS (University of Adelaide) as he discusses this exciting paper, presented at Heart Rhythm 2025. He is joined in the Heart Rhythm Tv Studio in San Diego, California by Louise Segan, MBBS, MPH (Alfred Health), and Takanori Yamaguchi, MD, PhD (Saga University). This discussion took place on-site at Heart Rhythm 2025.
Learning Objectives
  • Discuss the use of catheter ablation in treating atrial fibrillation in patients with cardiac amyloidosis and sarcoidosis.
Article Authors and Podcast Contributors
Article Authors

Alireza Oraii, Arian Afzalian, Oriol Rodriguez-Queralto, Corentin Chaumont, Adrian Petzl, Jenna Spears, Rahul Myadam, Balaram Krishna J. Hanumanthu, Matthew C. Hyman, Timothy Markman, Poojita Shivamurthy, Ramanan Kumareswaran, Robert D. Schaller, Gregory E. Supple, David S. Frankel, Fermin C. Garcia, Sanjay Dixit, Saman Nazarian, Francis E. Marchlinski

Podcast Contributors

Prashanthan Sanders, MBBS, PhD, FHRS, University of Adelaide
Louise Segan, MBBS, MPH, Alfred Health 
Takanori Yamaguchi, MD, PhD, Saga University

Faculty and Disclosures
All relevant financial relationships have been mitigated.

Host Disclosure(s):

P. Sanders:
Honoraria/Speaking/Consulting: Boston Scientific, Abbott Medical, Research: Boston Scientific, Abbott, Medtronic, Becton Dickinson, CathRx, Pacemate, Kalyan Technologies, Ceryx Medical, Biosense Webster, Inc., Hello Alfred, Abbott Medical
Membership on Advisory Committees: Pacemate, Medtronic PLC, Boston Scientific, CathRx, Abbott Medical

Contributor Disclosure(s):

T. Yamaguchi
:
Honoraria/Speaking/Consulting: Abbott Japan, Biotronik, Boston Scientific, Abbott Medical, Japan Medtronic, Inc.,
Daiichi Sankyo, Novartis, Japan Lifeline, Nihon Kohden, Bayer Healthcare Pharmaceuticals Japan, Boehringer Ingelheim


L. Segan
:
Nothing to disclose.
 

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
S. Sailor: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.
Summary
Availability:
On-Demand
Cost:
FREE
Credit Offered:
No Credit Offered
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Cookie Declaration | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By